Clinical Trials Directory

Trials / Completed

CompletedNCT01035125

Effect of One Week Self-management Program in Patients With Fibromyalgia

A Study of Effect of One Week Self-management Program in Patients With Fibromyalgia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
153 (actual)
Sponsor
Revmatismesykehuset AS · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to explore the effect of one week inpatient self-management program (SMP) in patients with fibromyalgia. The SMP is delivered as group education/activities by allied health professionals.

Detailed description

This study will determine if one week inpatient SMP can reduce FM symptoms and increase patients self-efficacy, health status, quality of life and being active health consumers. The one-week SMP is designed to help people manage their rheumatic disease and challenges in daily life. The program has the same core concepts as outpatient programmes and comprises information, discussions on how to cope with the disease and daily life, cognitive management skills, exercise, engagement in self-care and interactions with healthcare professionals. During the program, the inpatient education unit takes up to 16 patients and 5 relatives per week within one diagnostic group. Each educational session lasts for 1.5-2.5 hours and the physical activity sessions for 0.5-1 hour. In the evening group sessions, the patients are divided into small groups of approximately five participants. They talk together for one hour under leadership of one health professional who is educated in coaching. The focus is on coping with the disease and daily life. For the intervention group there will be a one year follow up study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSelf-management programParticipants will receive a one week inpatient self-management program

Timeline

Start date
2008-12-01
Primary completion
2011-02-01
Completion
2011-07-01
First posted
2009-12-18
Last updated
2011-07-28

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01035125. Inclusion in this directory is not an endorsement.